At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
Spasticity: Take Control +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Developing and Testing a Comprehensive MS Spasticity Management Program
In Brief
A Phase 2 clinical trial evaluating Spasticity: Take Control and Usual care for Multiple Sclerosis and Spasticity. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This is a study to determine the impact of education and specific lower extremity stretches for MS-related spasticity. The study will evaluate the acceptance and efficacy of education and stretching using a randomized controlled pilot trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis, Spasticity
CountriesUnited States
CollaboratorsOregon Health and Science University
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartOct 2015
Primary CompletionMay 2016
Study CompletionJun 2016
TodayJul 2026
First PostedJun 23, 2014
Enrollment StartOct 1, 2015
Primary CompletionMay 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.0 years ago
Interventions
Spasticity: Take Controlbehavioral
4 visits: baseline, view and discuss DVDs, practice stretching, outcome measures
Usual careother
2 visits: baseline followed by usual care of brochure for stretching then outcome measures